Vimarsana
Biggest News Aggregation in the World

Cystatin C News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cystatin C. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cystatin C Today - Breaking & Trending Today

eGFR is more strongly associated with adverse outcomes when cystatin C is included - Vimarsana News

eGFR is more strongly associated with adverse outcomes when cystatin C is included

1. In this cohort study, estimated glomerular filtration rate based on both creatinine and cystatin C (eGFRcr-cys ) was more strongly associated with cardiovascular events than estimates based on creatinine alone (eGFRcr). 2. Nearly one-third of individuals were reclassified into a different severity category after recalculation. Evidence Rating Level: 2 (Good) Study Rundown: GFR is used

eGFR Based on Creatinine, Cystatin C May Offer Better CKD Threshold for Older Adults - Vimarsana News

eGFR Based on Creatinine, Cystatin C May Offer Better CKD Threshold for Older Adults

Low eGFRcr-cys was more strongly and uniformly associated with adverse outcomes compared to low eGFRcr in an older patient population, highlighting the benefit of including cystatin C in GFR estimation.

UACR, eGFR Associated with Hospitalizations, Other Adverse Outcomes - Vimarsana News

UACR, eGFR Associated with Hospitalizations, Other Adverse Outcomes

Findings from a meta-analysis are calling attention to the viability of classification and risk stratification using greater albuminuria and decreased eGFR.

Test may help reduce racial disparities in kidney disease - Vimarsana News

Test may help reduce racial disparities in kidney disease

Researchers found that measuring levels of a protein called cystatin C can accurately estimate kidney function without needing to take race into account.

Source: nih.gov